Afrigen Business Rescue: Cape Town Biotech Firm Seeks Investors
Cape Town biotech firm Afrigen’s business rescue begins as the WHO-backed mRNA hub seeks new investment to secure vaccine manufacturing.
Regulatory Delays Threaten Africa’s Pharmaceutical Ambition
Regulatory delays are hindering Africa's R1.25-trillion pharmaceutical manufacturing goals and access to markets.
Local Medicine Manufacturing and National Health Security
Explore the future of local medicine manufacturing as Sahpra fast-tracks evaluation to secure South Africa's national supply.
Biovac Secures Deal to Produce Pneumonia Vaccine
Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.